JP2011224009A5 - - Google Patents

Download PDF

Info

Publication number
JP2011224009A5
JP2011224009A5 JP2011118610A JP2011118610A JP2011224009A5 JP 2011224009 A5 JP2011224009 A5 JP 2011224009A5 JP 2011118610 A JP2011118610 A JP 2011118610A JP 2011118610 A JP2011118610 A JP 2011118610A JP 2011224009 A5 JP2011224009 A5 JP 2011224009A5
Authority
JP
Japan
Prior art keywords
medium
stem cell
avian
serum
vaccinia virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011118610A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011224009A (ja
JP5416169B2 (ja
Filing date
Publication date
Priority claimed from EP03291813A external-priority patent/EP1500699A1/en
Application filed filed Critical
Publication of JP2011224009A publication Critical patent/JP2011224009A/ja
Publication of JP2011224009A5 publication Critical patent/JP2011224009A5/ja
Application granted granted Critical
Publication of JP5416169B2 publication Critical patent/JP5416169B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2011118610A 2003-07-22 2011-05-27 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法 Expired - Fee Related JP5416169B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03291813A EP1500699A1 (en) 2003-07-22 2003-07-22 Production of vaccinia virus with adherent or non adherent avian cell lines
EP03291813.8 2003-07-22
FR0314389 2003-12-09
FR0314389 2003-12-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006520937A Division JP4787156B2 (ja) 2003-07-22 2004-07-22 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法

Publications (3)

Publication Number Publication Date
JP2011224009A JP2011224009A (ja) 2011-11-10
JP2011224009A5 true JP2011224009A5 (enExample) 2012-08-09
JP5416169B2 JP5416169B2 (ja) 2014-02-12

Family

ID=34081825

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006520937A Expired - Fee Related JP4787156B2 (ja) 2003-07-22 2004-07-22 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法
JP2011118610A Expired - Fee Related JP5416169B2 (ja) 2003-07-22 2011-05-27 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006520937A Expired - Fee Related JP4787156B2 (ja) 2003-07-22 2004-07-22 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法

Country Status (14)

Country Link
US (3) US7432101B2 (enExample)
EP (2) EP1646715B1 (enExample)
JP (2) JP4787156B2 (enExample)
KR (1) KR101121971B1 (enExample)
AT (1) ATE467678T1 (enExample)
AU (1) AU2004257939B2 (enExample)
CA (1) CA2531565C (enExample)
DE (1) DE602004027141D1 (enExample)
DK (1) DK1646715T3 (enExample)
ES (1) ES2345820T3 (enExample)
PL (1) PL1646715T3 (enExample)
PT (1) PT1646715E (enExample)
SI (1) SI1646715T1 (enExample)
WO (1) WO2005007840A1 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) * 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
UA85543C2 (ru) * 2002-09-05 2009-02-10 Бавариан Нордик А/С Способ культивирования первичных клеток и амплификации вирусов в условиях безсывороточной среды, композиция и ее применение, и способ лечения или вакцинации животных
JP4787156B2 (ja) * 2003-07-22 2011-10-05 ビバリス 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
AU2011253998B2 (en) * 2005-04-11 2014-04-24 Valneva Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
FR2898909A1 (fr) 2006-03-24 2007-09-28 Agronomique Inst Nat Rech Combinaison de marqueurs de cellules aviaires
WO2007135133A1 (en) * 2006-05-19 2007-11-29 Vivalis Avian cell lines derived from primordial germ cells useful for the production of substances of interest
KR101082296B1 (ko) 2006-06-20 2011-11-09 트랜스진 에스.에이. 폭스바이러스 및 폭스바이러스 조성물 제조 방법
EP2500417A1 (en) 2006-08-09 2012-09-19 Vivalis Method of production of transgenic avian using embryonic stem cells
WO2008109674A2 (en) * 2007-03-05 2008-09-12 Caridianbct, Inc. Cell expansion system and methods of use
EP1985305A1 (en) * 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
CN101688182A (zh) 2007-07-03 2010-03-31 特兰斯吉恩股份有限公司 永生化禽细胞系
PL214884B1 (pl) * 2008-09-29 2013-09-30 Inst Immunologii I Terapii Doswiadczalnej Pan Test ELISA do wykrywania w surowicy bydlecej przeciwcial przeciwko antygenowi powierzchniowemu gp51 BLV
EP2379598B1 (en) 2009-01-19 2015-03-11 Innate Pharma Anti-kir3d antibodies
CA2750055A1 (en) * 2009-02-06 2010-08-12 Glaxosmithkline Biologicals S.A. Method for purifying viruses using a density gradient
KR20120026526A (ko) 2009-05-12 2012-03-19 트랜스진 에스.에이. 불멸화 조류 세포주 및 그의 용도
NZ603620A (en) 2010-07-20 2015-01-30 Bavarian Nordic As Method for harvesting expression products
US10214722B2 (en) * 2010-09-07 2019-02-26 Technion Research & Development Foundation Limited Methods for expanding and maintaining human pluripotent stem cells (PSCs) in an undifferentiated state in a single cell suspension culture
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
EP2660316A1 (en) 2012-05-02 2013-11-06 Helmholtz-Zentrum für Infektionsforschung GmbH Avian cell line and its use in production of protein
US20140255447A1 (en) * 2013-03-05 2014-09-11 Biomune Company Production of avian embryo cells
WO2015073918A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
US10077421B2 (en) 2014-04-24 2018-09-18 Terumo Bct, Inc. Measuring flow rate
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
AU2015357225B2 (en) 2014-12-01 2020-04-09 Transgene Sa Stable liquid vaccinia virus formulations
WO2016088243A1 (ja) * 2014-12-05 2016-06-09 株式会社ニコン 判定装置、観察システム、観察方法、そのプログラム、細胞の製造方法、および細胞
WO2016128542A1 (en) 2015-02-13 2016-08-18 Transgene Sa Immunotherapeutic vaccine and antibody combination therapy
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3452081A1 (en) 2016-05-04 2019-03-13 Transgene SA Combination therapy with cpg tlr9 ligand
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US20190328869A1 (en) 2016-10-10 2019-10-31 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
JP7406377B2 (ja) 2017-05-15 2023-12-27 ヤンセン ファッシンズ アンド プリベンション ベーフェー 安定なウイルス含有組成物
US11306292B2 (en) 2017-05-15 2022-04-19 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
KR102684237B1 (ko) 2017-06-21 2024-07-11 트랜스진 개인 맞춤형 백신
MX2020012895A (es) 2018-05-30 2021-05-27 Inst Res Biomedicine Modificacion de linfocitos b al utilizar citidina desaminasa inducida por activacion endogena.
CA3111273C (en) 2018-09-06 2024-03-26 Bavarian Nordic A/S Storage improved poxvirus compositions
KR20210094554A (ko) 2018-11-23 2021-07-29 발네바 에스이 조류 줄기 세포를 포함하는 식품
CN113227354A (zh) * 2019-01-17 2021-08-06 勃林格殷格翰动物保健美国公司 用于禽类疫苗生产的无血清培养基及其用途
JP7712284B2 (ja) 2020-03-12 2025-07-23 バヴァリアン・ノルディック・アクティーゼルスカブ ポックスウイルスの安定性を改善する組成物
CA3183701A1 (en) * 2020-06-22 2021-12-30 Sung Jin Kim Method for large scale-production of vaccinia virus using suspension cells
TW202217002A (zh) 2020-07-13 2022-05-01 法商傳斯堅公司 免疫抑制之治療
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340740A (en) 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
FR2726003B1 (fr) 1994-10-21 2002-10-18 Agronomique Inst Nat Rech Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
US5672485A (en) 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
PT841392E (pt) 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
DE60302654T2 (de) * 2002-02-19 2006-09-14 Cellergy Ltd. Elektrochemischer kondensator und dessen herstellung
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
CA2510229A1 (en) * 2002-12-13 2004-07-08 Aventis Pasteur, Inc. Production of alvac on avian embryonic stem cells
JP4787156B2 (ja) * 2003-07-22 2011-10-05 ビバリス 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法
EP1528101A1 (en) * 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production

Similar Documents

Publication Publication Date Title
JP2011224009A5 (enExample)
JP2006527995A5 (enExample)
JP4787156B2 (ja) 付着または非付着の鳥類細胞系を用いた、ポックスウィルスの作製法
US9822345B2 (en) Method of making a virus using duck embryonic derived stem cell lines
JP5031726B2 (ja) 懸濁鳥類胚性幹細胞株においてウイルスワクチンを製造する方法
JP2012110344A5 (enExample)
CN1826406A (zh) 用附着或非附着鸟细胞系生产痘病毒
CN100455661C (zh) 一种禽类精原干细胞的体外培养方法
Hussain et al. Adaptation of an indigenous very virulent infectious bursal disease virus on Vero cell line.
Martin et al. How to limit the use of serum in viral processes: A gibco perspective
SUHAIROSLINDA-HAYATI ADAPTATION OF INFECTIOUS BRONCHITIS VIRUS IN MAMMALIAN CELL LINE MJ SUHAIROSLINDA-HAYATI1, M. HAIR-BEJO1, 2, SS ARSHAD1 and AR OMAR1, 2
AU2011253998A1 (en) Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines